| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |